Consensus Abbott Laboratories Deutsche Boerse AG

Stocks

ABL

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 02:00:46 2026-08-14 am EDT			5-day change	1st Jan Change
96.04 ^EUR	-0.23%		+2.13%	-8.97%

Aug. 13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
Aug. 13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT

Evolution of the Average Target: Abbott Laboratories

Evolution of the Target Price: Abbott Laboratories

Changes in Analyst Recommendations: Abbott Laboratories

b15f690c54802ce48f4.ct9GP-vfJtl5TfamQ681FLL9xPFhL9qB6TLZKbzSmvQ.FKx0VaPnUasUC73zMtkCctm4gsZXTbXCpgaAaNG86qwwugBuqLBPqQsonQ~570fc520d20029c0b5fa829a2a84aa04

Analysts' recommendations: Abbott Laboratories

Aug. 13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
Aug. 13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
Jul. 28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
Jul. 28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
Jul. 23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
Jul. 22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
Jul. 17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
Jul. 17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
Jul. 17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
Jul. 17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
Jul. 17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
Jul. 17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
Jul. 17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
Jul. 16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
Jul. 06	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
Jul. 01	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
Jun. 12	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
May. 27	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
May. 05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
Apr. 22	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…
Apr. 22	Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113	MT
Apr. 21	Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating	MT
Apr. 21	Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating	MT
Apr. 20	Argus Cuts Abbott Laboratories' Price Target to $125 From $140	MT
Apr. 20	UBS Adjusts Abbott Laboratories Price Target to $135 From $158, Maintains Buy Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+7.33%
	MEDTRONIC PLC					+7.86%
	CENCORA, INC.					+18.73%
	HOYA CORPORATION					+14.67%
	BECTON, DICKINSON AND COMPANY					+6.01%
	DEXCOM, INC.					+4.87%
	MEDLINE INC.					+24.83%
	TERUMO CORPORATION					+16.37%
	WEST PHARMACEUTICAL SERVICES, INC.					+15.83%
	Average					+12.94%
	Weighted average by Cap.					+10.70%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

111.25USD

Average target price

119.40USD

Spread / Average Target

+7.33%

High Price Target

135.00USD

Spread / Highest target

+21.35%

Low Price Target

103.00USD

Spread / Lowest Target

-7.42%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Citigroup
Wolfe Research
UBS
Rothschild & Co Redburn
Daiwa Securities
Leerink Partners
BTIG
Evercore ISI
Bernstein
Piper Sandler
JPMorgan Chase
Wells Fargo Securities
Baird
BofA Securities
Goldman Sachs
Argus
Oppenheimer
TD Cowen
Benchmark Company
Stifel Nicolaus
Jefferies & Co.
Mizuho Securities
RBC Capital Markets
Raymond James
Barclays
Morgan Stanley
Redburn Atlantic
Nephron Research
Morningstar
Atlantic Equities
SVB Leerink
Redburn
Cowen
Credit Suisse
J.P. Morgan Chase